《全日速報》恆指跌417點; 恆生科技指數跌88點 平安跌逾4% 美團跌逾3% 首程控股創新高 成交暢旺
恆指全日收19,560點,跌417點或2.1%。恆生科技指數報3,870點,跌88點或2.2%。國指跌152點或2.2%,報6,636點。大市成交額1,016.05億元。
活躍重磅股表現:
平安(02318.HK) 收55.1元,下跌4.4%;
美團(03690.HK) 收133元,下跌3.2%;
友邦(01299.HK) 收79.2元,下跌2.5%;
港交所(00388.HK) 收305.8元,下跌1.9%;
建行(00939.HK) 收5.29元,下跌1.3%;
騰訊(00700.HK) 收342.8元,下跌0.6%;
阿里巴巴(09988.HK) 收85.45元,下跌0.3%;
異動恆指及國指成份股:
碧桂園服務(06098.HK) 收10.06元,下跌7.7%;
龍湖(00960.HK) 收18.62元,下跌7.1%;
中升控股(00881.HK) 收31.95元,下跌6%;
信義玻璃(00868.HK) 收12.6元,下跌5.5%;
京東健康(06618.HK) 收49.7元,下跌5.3%;
碧桂園(02007.HK) 收1.62元,下跌5.3%;
申洲(02313.HK) 收63.45元,下跌5.2%;
創科(00669.HK) 收78.75元,下跌5%;
華潤置地(01109.HK) 收32.5元,下跌4.8%;
安踏體育(02020.HK) 收86.9元,下跌4.5%;
翰森製藥(03692.HK) 收12.76元,下跌4.3%;
新奧能源(02688.HK) 收109.3元,下跌4.2%;
阿里健康(00241.HK) 收4.87元,下跌4.1%;
中生製藥(01177.HK) 收3.96元,下跌4.1%;
恆隆地產(00101.HK) 收12.46元,下跌4%;
藥明生物(02269.HK) 收44.85元,下跌4%;
中國海外發展(00688.HK) 收18.42元,下跌3.9%;
石藥(01093.HK) 收7.53元,下跌3.8%;
信義光能(00968.HK) 收8元,下跌3.6%;
小鵬汽車(09868.HK) 收36.5元,下跌3.6%;
李寧(02331.HK) 收48.55元,下跌3.5%;
舜宇(02382.HK) 收81.35元,下跌3.4%;
周大福(01929.HK) 收14.76元,下跌3.4%;
小米集團(01810.HK) 收10.84元,下跌3.4%;
新世界發展(00017.HK) 收19.42元,下跌3.4%;
海爾智家(06690.HK) 收22.85元,下跌3.4%;
京東物流(02618.HK) 收12.68元,下跌3.2%;
異動綜合中小型股:
高鑫零售(06808.HK) 收2.59元,下跌22.7%;
萬國數據(09698.HK) 收9.79元,下跌11%;
康方生物(09926.HK) 收37.65元,下跌10.8%;
首程控股(00697.HK) 收2.22元,上升1.4%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.